Epidemiological characteristics of pregnancy, delivery, and birth outcome in women with multiple sclerosis in Argentina (EMEMAR study)

Multiple Sclerosis

Volumn 15, Issue 5, 2009, Pages 555-562

  Fernández Liguori, Nora ^a   Klajn, D ^a   Acion, L ^b   Caceres F ^c   Calle, A ^d   Carra A ^d   Cristiano, E ^f   Deri, N ^g   Garcea, O ^h   Jaureguiberry, A ^h   Onaha, P ^e   Patrucco, L ^f   Riccio, P ^f   Rotta Escalante, R ^h   Saladino, M L ^a,c   Sinay, V ^d   Tarulla, A ^h   Villa, A ^h  

^a Tornu Hospital   (Argentina)

^b UNIVERSITY OF IOWA   (United States)

^c Multiple Sclerosis Clinic Instituto Neurociencias Buenos Aires (INEBA)   (Argentina)

^d HOSPITAL FRANCÉS   (Argentina)

^e HOSPITAL BRITÁNICO DE BUENOS AIRES   (Argentina)

^f HOSPITAL ITALIANO DE BUENOS AIRES   (Argentina)

^g Hospital J Fernández   (Argentina)

^h HOSPITAL RAMOS MEJÍA   (Argentina)

Author keywords

Immunomodulatory treatment; Multiple sclerosis; Pregnancy; Relapse rate

Indexed keywords

BETA1A INTERFERON; GLATIRAMER; IMMUNOMODULATING AGENT; INTERFERON BETA SERINE;

ABORTION; ADULT; AGED; ARGENTINA; ARTICLE; BIRTH DEFECT; CONTROLLED STUDY; DELIVERY; FEMALE; FIRST TRIMESTER PREGNANCY; HUMAN; MAJOR CLINICAL STUDY; MULTIPLE SCLEROSIS; PREGNANCY; PREGNANCY OUTCOME; PRENATAL DRUG EXPOSURE; PUERPERIUM; RECURRENCE RISK; RETROSPECTIVE STUDY; SECOND TRIMESTER PREGNANCY; THIRD TRIMESTER PREGNANCY;

ADULT; AGED; ARGENTINA; BREAST FEEDING; CONGENITAL ABNORMALITIES; DATA COLLECTION; DELIVERY, OBSTETRIC; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFANT, NEWBORN; MIDDLE AGED; MULTIPLE SCLEROSIS; POSTPARTUM PERIOD; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; PREGNANCY TRIMESTER, SECOND; PREGNANCY TRIMESTER, THIRD; RETROSPECTIVE STUDIES; RISK FACTORS; YOUNG ADULT;

EID: 65349189955     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1177/1352458509102366     Document Type: Article

References (28)

1. Confavreux C Hutchinson M Hours MM Cortinovis-Tourniaire P Moreau T. Rate of pregnancy-related relapse in multiple sclerosis. N Engl J Med 1998; 339: 285-291.
2. Randall K Davis K Maslow S. Multiple sclerosis and pregnancy: A review. Obstet Gynecol Surv 1992; 47: 290-296.
3. Hutchinson M. Pregnancy in multiple sclerosis. J Neurol Neurosurg Psychiatry 1993; 56: 1043-1045.
4. Sadovnick A Ebers G. Epidemiology of multiple sclerosis: A critical overview. Can J Neurol Sci 1993; 20: 17-29.
5. Sadovnick A Eisen K Hashimoto S. Pregnancy and multiple sclerosis. A prospective study. Arch Neurol 1994; 51: 1120-1124.
6. Abramsky O. Pregnancy and multiple sclerosis. Ann Neurol 1994; 36: S38-S41.
7. Lorenzi A Ford H. Multiple sclerosis and pregnancy. Postgrad Med J 2002; 78: 460-464.
8. Ferrero S Pretta S Ragni N. Multiple sclerosis: Management issues during pregnancy. Eur J Obstet Gynecol Reprod Biol 2004; 115: 3-9.
9. www.nmss.org
10. Correale J Patrucco L Cristiano E. Consenso sobre el uso de drogas Inmunomoduladoras en el tratamiento de la Esclerosis Múltiple en la Argentina. Rev Neurol Arg 2000; 25: 134-178.
11. Correale J Bettinelli R Brizuela JA. Actualización del consenso sobre el uso de drogas Inmunomoduladoras en el tratamiento de la Esclerosis Móltiple en la Argentina. Rev Neurol Arg 2003; 28: 55-57.
12. Dwosh E Guimond C Sadovnik AD. Reproductive counseling in MS: A guide for healthcare professionals. Int MS J 2003; 10: 67.
13. Sandberg-Wollheim M Frank D Goodwin TM. Pregnancy outcomes during treatment with interferon beta 1a in patients with multiple sclerosis. Neurology 2005; 65: 802-806.
14. Boskovic R Wade R Wolpin J Bauer DJ Koren G. The reproductive effects of beta interferon therapy in pregnancy: A longitudinal cohort. Neurology 2005; 65: 807-811.
15. Coyle PK; Johnson K; Pardo L; Stark Y;. Pregnancy outcomes in patients with multiple sclerosis treated with glatiramer acetate (Copaxone). Neurology 2003; 60(Suppl. 1): A60.
16. De Las Heras V De Andrés C Tellez N Tintore M. Pregnancy in multiple sclerosis patients treated with immunomodulators prior to or during pregnancy: A descriptive study in the Spanish population. Mult Scler 2007; 13: 981-984.
17. Hellwig K Brune N Haghikia A. Reproductive counseling, treatment and course of pregnancy in 73 German MS patients. Acta Neurol Scand 2008.
18. http://www.cdc.gov/EpiInfo/
19. SAS Institute Inc. SAS 9.1.3 Service Pack 3 for Windows XP professional. Carry (NA): SAS Institute Inc., 2004.
20. Dahl J Myhr KM Daltveit AK Hoff JM Gilhus NE. Pregnancy, delivery and birth outcome in women with multiple sclerosis. Neurology 2005; 65: 1961-1963.
21. Villar J Valladares E Wojdyla D. Caesarean delivery rates and pregnancy outcomes: The 2005 WHO global survey on maternal and perinatal health in Latin America. Lancet 2006; 367: 1819-1829.
22. Runmarker B Andersen O. Pregnancy is associated with a lower risk of onset and a better prognosis in multiple sclerosis. Brain 1995; 118: 254-261.
23. Salemi G Callari G Gammino M. The relapse rate of multiple sclerosis changes during pregnancy: A cohort study. Acta Neurol Scand 2004; 110: 23-26.
24. Korn-Lubetzki I Kahana E Cooper G Abramsky O. Activity of multiple sclerosis during pregnancy and puerperium. Ann Neurol 1984; 16: 229-231.
25. Vukusic S Hutchinson M Hours M. Pregnancy and multiple sclerosis (the PRIMS study): Clinical predictors of post-partum relapse. Brain 2004; 127: 1353-1360.
26. http://www.emea.europa.eu/humandocs/PDFs/EPAR/Rebif/H-136-PI-es.pdf
27. http://www.emea.europa.eu/humandocs/PDFs/EPAR/Betaferon/H-081-PI-en.pdf
28. http://www.emea.europa.eu/humandocs/PDFs/EPAR/avonex/H-102-PI-en.pdf